Skip header and navigation

Refine By

8 records – page 1 of 1.

Body size and lifestyle in an urban population entering adulthood: the 'Grow up Gothenburg' study.

https://arctichealth.org/en/permalink/ahliterature124485
Source
Acta Paediatr. 2012 Sep;101(9):964-72
Publication Type
Article
Date
Sep-2012
Author
Agneta Sjöberg
Marie-Louise Barrenäs
Ebba Brann
John Eric Chaplin
Jovanna Dahlgren
Staffan Mårild
Lauren Lissner
Kerstin Albertsson-Wikland
Author Affiliation
Department of Public Health and Community Medicine, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Sweden. agneta.sjoberg@gu.se
Source
Acta Paediatr. 2012 Sep;101(9):964-72
Date
Sep-2012
Language
English
Publication Type
Article
Keywords
Adolescent
Body Height
Body Image
Body Size
Body Weight
Exercise
Female
Food Habits
Health status
Humans
Life Style
Male
Self Concept
Sleep
Sweden
Urban Population - statistics & numerical data
Waist Circumference
Young Adult
Abstract
To present data on body size, lifestyle and health status in students in their final year in high schools in Gothenburg area, Sweden, with specific attention to origin and gender.
Weight, height and waist circumference were measured by standardized procedures. Self-administered questionnaires described dietary habits, sleep, physical activity, body image, country of origin and general health.
Eighty-six percent of participants, (2600 girls, 2714 boys, mean age 18.6 years) were of Nordic origin, 86% reported no chronic health problems and 14%/19% of girls/boys were overweight or obese. Girls consumed more vegetables and fruits and fewer sweet drinks than boys, while breakfast consumption was most common in Nordic groups. Boys reported more positive answers than girls regarding body image. Nordic girls had more negative body image and higher morbidity compared with other groups.
Within this generally healthy cohort, boys were more likely to be overweight/obese than girls, although paradoxically boys were more satisfied with their appearance. Nordic girls constitute a group with particularly high risk of reporting low body self-esteem and chronic morbidity. In the longer term, the current cross-sectional data on body size, lifestyle and health will provide important baseline information for future follow-up studies of health outcomes in later life.
PubMed ID
22577752 View in PubMed
Less detail

Declining Well-Being in Young Swedes Born in 1990 Versus 1974.

https://arctichealth.org/en/permalink/ahliterature289962
Source
J Adolesc Health. 2017 Mar; 60(3):306-312
Publication Type
Comparative Study
Journal Article
Date
Mar-2017
Author
Ebba Brann
John E Chaplin
Monica Leu Agelii
Agneta Sjöberg
Aimon Niklasson
Kerstin Albertsson-Wikland
Lauren Lissner
Author Affiliation
Section for Epidemiology and Social Medicine (EPSO), Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address: ebba.brann@gu.se.
Source
J Adolesc Health. 2017 Mar; 60(3):306-312
Date
Mar-2017
Language
English
Publication Type
Comparative Study
Journal Article
Keywords
Adolescent
Adult
Affect
Body Height
Body Weight
Cohort Studies
Cross-Sectional Studies
Female
Health status
Humans
Male
Self Concept
Self Report
Stress, Psychological - epidemiology
Surveys and Questionnaires
Sweden - epidemiology
Time
Young Adult
Abstract
Well-being is affected by the environment, including societal changes. In this study, specific dimensions of well-being were compared in two cohorts of Swedish adolescents born 16 years apart.
Two groups of 18-year-olds, "Grow up Gothenburg" 1974 and 1990 birth cohorts, completed a self-reported questionnaire including the Gothenburg Well-Being in adolescence scale (GWBa). In addition, height and weight were measured, resulting in 4,362 participants (1974 birth cohort) and 5,151 participants (1990 birth cohort) with age, height, weight, and well-being data. The GWBa consists of a total score and five dimensions: mood, physical condition, energy, self-esteem, and stress balance.
Total well-being was significantly lower in the later-born cohort, and the greatest difference was seen for the dimension stress balance (feeling calm, unconcerned, unstressed, and relaxed), although effect sizes were modest. In both boys and girls, well-being was lower for all dimensions in the later-born cohort, with the exception of Self-esteem in girls, which was higher in the later-born cohort. In both cohorts, boys reported higher well-being than girls for all dimensions. The mean body mass index z-score was higher in boys from the later-born cohort, but after adjusting for weight status, the differences in well-being between the cohorts persisted.
Well-being was lower in the later-born cohort, particularly for the dimension stress balance. Differences were not explained by the shift in weight status indicating that other societal changes have had an impact on well-being levels. Managing high levels of stress might be an area of intervention in adolescents for improved well-being.
PubMed ID
27993460 View in PubMed
Less detail
Source
J Pediatr Endocrinol Metab. 2002 Dec;15 Suppl 5:1243-55
Publication Type
Article
Date
Dec-2002
Author
Johan Karlberg
Kerstin Albertsson-Wikland
Chi Wai Kwan
Flora Y S Chan
Author Affiliation
Clinical Trials Centre, Faculty of Medicine, The University of Hong Kong. Hong Kong SAR, PR China. jpekarl@hkucc.hku.hk
Source
J Pediatr Endocrinol Metab. 2002 Dec;15 Suppl 5:1243-55
Date
Dec-2002
Language
English
Publication Type
Article
Keywords
Body Height
Child
Child, Preschool
Embryonic and Fetal Development
Growth
Humans
Infant
Infant, Newborn
Infant, Small for Gestational Age
Insulin-Like Growth Factor I - analysis
Research Support, Non-U.S. Gov't
Abstract
We explored factors related to early catch-up growth in healthy children in Göteborg, Sweden. Most (82.9%) infants born small for gestational age (SGA) showed catch-up growth during their first 6 months, and 94.3% reached a final height within the normal range. At 6 months, 21 SGA children remained short and 45 non-SGA babies fell below the -2 SDS cutoff in height. Of these 66 short infants, 10 (15.2%) remained short into adulthood and 56 showed spontaneous catch-up growth. Fetal growth should be defined by body size at 6 months of age rather than at birth because most SGA infants catch up before 6 months, and furthermore, fetal growth regulatory mechanisms, such as insulin-like growth factor-I and -II, are the primary growth-promoting factors until 6 months of age.
PubMed ID
12510975 View in PubMed
Less detail

Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

https://arctichealth.org/en/permalink/ahliterature274993
Source
BMC Endocr Disord. 2015;15:84
Publication Type
Article
Date
2015
Author
Elena Lundberg
Berit Kriström
Bjorn Jonsson
Kerstin Albertsson-Wikland
Source
BMC Endocr Disord. 2015;15:84
Date
2015
Language
English
Publication Type
Article
Keywords
Adolescent
Body Height - drug effects
Dose-Response Relationship, Drug
Female
Growth - drug effects
Growth Disorders - drug therapy - physiopathology
Human Growth Hormone - administration & dosage - blood - secretion
Humans
Infant, Small for Gestational Age
Insulin-Like Growth Factor I - metabolism
Male
Puberty - metabolism
Sweden - epidemiology
Treatment Outcome
Abstract
Responsiveness to GH treatment can be estimated by both growth and ?IGF-I. The primary aim of the present study was to investigate if mimicking the physiological increase during puberty in GH secretion, by using a higher GH dose could lead to pubertal IGFs in short children with low GH secretion. The secondary aim was to explore the relationship between IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 ratio and gain in height.
A multicentre, randomized, clinical trial (TRN88-177) in 104 children (90 boys), who had received GH 33 µg/kg/day during at least 1 prepubertal year. They were followed from GH start to adult height (mean, 7.5 years; range, 4.6-10.7). At onset of puberty, children were randomized into three groups, to receive 67 µg/kg/day (GH(67)) given once (GH(67x1); n?=?30) or divided into two daily injection (GH(33x2); n?=?36), or to remain on a single 33 µg/kg/day dose (GH(33x1); n?=?38). The outcome measures were change and obtained mean on-treatment IGF-I(SDS), IGFBP3(SDS) and IGF-I/IGFBP3 ratio(SDS) during prepuberty and puberty. These variables were assessed in relation to prepubertal, pubertal and total gain in heightSDS.
Mean prepubertal increases 1 year after GH start were: 2.1 IGF-I(SDS), 0.6 IGFBP3(SDS) and 1.5 IGF-I/IGFBP3ratio(SDS). A significant positive correlation was found between prepubertal ?IGFs and both prepubertal and total gain in height(SDS). During puberty changes in IGFs were GH dose-dependent: mean pubertal level of IGF-I(SDS) was higher in GH(67) vs GH(33) (p?=?0.031). First year pubertal ?IGF-I(SDS) was significantly higher in the GH(67)vs GH(33) group (0.5 vs -0.1, respectively, p?=?0.007), as well as ?IGF-I(SDS) to the pubertal mean level (0.2 vs -0.2, p?=?0.028). In multivariate analyses, the prepubertal increase in '?IGF-I(SDS) from GH start' and the 'GH dose-dependent pubertal ?IGF-I(SDS)' were the most important variables for explaining variation in prepubertal (21 %), pubertal (26 %) and total (28 %) gain in height(SDS).
TRN 88-177, not applicable 1988.
The dose-dependent change in IGFs was related to a dose-dependent pubertal gain in height(SDS). The attempt to mimic normal physiology by giving a higher GH dose during puberty was associated with both an increase in IGF-I and a dose-dependent gain in height(SDS).
Notes
Cites: Lancet. 2004 Apr 24;363(9418):1346-5315110491
Cites: BMC Med Inform Decis Mak. 2009;9:119138407
Cites: J Clin Endocrinol Metab. 1981 Apr;52(4):622-77193684
Cites: Science. 1982 Jun 11;216(4551):1237-97079756
Cites: Growth Horm IGF Res. 2009 Feb;19(1):1-1118824380
Cites: Acta Paediatr. 2008 Dec;97(12):1698-70618976357
Cites: J Pediatr Endocrinol Metab. 2009 Jul;22(7):623-819774843
Cites: Horm Res Paediatr. 2010;74(3):172-8120424418
Cites: J Clin Endocrinol Metab. 2010 Sep;95(9):4449-5420610598
Cites: PLoS One. 2011;6(1):e1622321305004
Cites: J Clin Endocrinol Metab. 2014 Aug;99(8):2917-2424823461
Cites: Horm Res Paediatr. 2014;82(3):158-7025170833
Cites: Horm Res Paediatr. 2014;82(3):143-425170997
Cites: Clin Endocrinol (Oxf). 2000 Sep;53(3):329-3610971450
Cites: Pediatr Res. 2000 Oct;48(4):475-8411004238
Cites: J Clin Endocrinol Metab. 2000 Oct;85(10):3653-6011061518
Cites: Horm Res. 2001;55(3):115-2411549872
Cites: J Clin Endocrinol Metab. 2001 Dec;86(12):5870-611739455
Cites: J Clin Endocrinol Metab. 2002 Jan;87(1):90-811788629
Cites: Acta Paediatr. 2002;91(7):739-5412200898
Cites: J Clin Endocrinol Metab. 2002 Oct;87(10):4754-6512364470
Cites: J Clin Endocrinol Metab. 2003 Oct;88(10):4748-5314557450
Cites: Differentiation. 1985;29(3):195-83908201
Cites: J Clin Endocrinol Metab. 1987 Oct;65(4):671-83654912
Cites: J Dev Behav Pediatr. 1989 Aug;10(4):207-152671046
Cites: Acta Paediatr Scand Suppl. 1989;356:26-372488676
Cites: Acta Paediatr Scand. 1991 Aug-Sep;80(8-9):756-621957592
Cites: J Clin Endocrinol Metab. 1994 Mar;78(3):744-528126152
Cites: J Clin Endocrinol Metab. 1994 May;78(5):1195-2018175978
Cites: FEBS Lett. 1994 Jul 11;348(2):185-918034039
Cites: Clin Endocrinol (Oxf). 1994 Jul;41(1):85-937519529
Cites: Clin Chem. 1997 Jun;43(6 Pt 1):950-69191545
Cites: Eur J Endocrinol. 1997 Aug;137(2):132-79272100
Cites: J Clin Endocrinol Metab. 1997 Sep;82(9):2889-989284715
Cites: J Clin Endocrinol Metab. 1997 Oct;82(10):3414-209329378
Cites: Endocrine. 1997 Dec;7(3):351-609657073
Cites: Pediatr Res. 1999 Mar;45(3):377-8310088658
Cites: Acta Paediatr Suppl. 1999 Feb;88(428):80-410102059
Cites: J Clin Endocrinol Metab. 1999 Apr;84(4):1174-8310199749
Cites: J Clin Endocrinol Metab. 2005 Jan;90(1):366-7115509643
Cites: J Clin Endocrinol Metab. 2005 Mar;90(3):1420-715598696
Cites: J Clin Endocrinol Metab. 2007 Jul;92(7):2480-617356043
Cites: Clin Ther. 2008 Feb;30(2):307-1618343269
Cites: J Endocrinol Invest. 2008 Feb;31(2):153-818362507
Cites: Pediatr Res. 2008 Jul;64(1):2-718652011
Cites: Horm Res. 2008;70(2):85-818547954
Cites: Acta Paediatr Scand Suppl. 1976;(258):7-761066960
PubMed ID
26682747 View in PubMed
Less detail

Growth in early life and its relation to pubertal growth.

https://arctichealth.org/en/permalink/ahliterature31217
Source
Epidemiology. 2003 Jan;14(1):65-73
Publication Type
Article
Date
Jan-2003
Author
Zhong Cheng Luo
Yin Bun Cheung
Qing He
Kerstin Albertsson-Wikland
Johan Karlberg
Author Affiliation
Clinical Trials Centre and Department of Pediatrics, University of Hong Kong, Pokfulam, The P R China.
Source
Epidemiology. 2003 Jan;14(1):65-73
Date
Jan-2003
Language
English
Publication Type
Article
Keywords
Adolescent - physiology
Body Height - physiology
Body mass index
Child
Child Development - physiology
Child, Preschool
Female
Growth - physiology
Humans
Infant
Longitudinal Studies
Male
Puberty - physiology
Research Support, Non-U.S. Gov't
Sweden
Abstract
BACKGROUND: The timing and magnitude of pubertal growth in relation to fetal, infancy and childhood growth have not been explored. METHODS: We used data from a longitudinal growth study of 3650 full-term healthy children who were born in Gothenburg, Sweden in 1973-1975. This analysis included 2738 children with height and weight measurements available both in early life and during adolescence. RESULTS: We found that faster linear growth during infancy and childhood was associated with earlier peak height velocity during adolescence. In contrast, greater height and body mass index (BMI) at birth were associated with later peak height velocity in adolescence. Children with faster linear growth and greater BMI in infancy and childhood had less height gain between ages 8 and 18. However, greater height and BMI at birth were associated with more height gain between ages 8 and 18 after adjusting for height and BMI in childhood. CONCLUSIONS: Both length and BMI (at birth, in infancy and during childhood) are associated with the timing and magnitude of pubertal growth. Being small at birth is associated with early puberty and a reduced height gain during adolescence.
PubMed ID
12500048 View in PubMed
Less detail

Improvements in behaviour and self-esteem following growth hormone treatment in short prepubertal children.

https://arctichealth.org/en/permalink/ahliterature137227
Source
Horm Res Paediatr. 2011;75(4):291-303
Publication Type
Article
Date
2011
Author
John Eric Chaplin
Berit Kriström
Björn Jonsson
Bruno Hägglöf
Torsten Tuvemo
A Stefan Aronson
Jovanna Dahlgren
Kerstin Albertsson-Wikland
Author Affiliation
Göteborg Pediatric Growth Research Center, Institute of Clinical Science, The Sahlgrenska Academy at University of Gothenburg, Göteborg, Sweden.
Source
Horm Res Paediatr. 2011;75(4):291-303
Date
2011
Language
English
Publication Type
Article
Keywords
Affect - drug effects
Attention - drug effects
Body Height - drug effects
Child
Child Behavior - drug effects
Child Behavior Disorders - etiology - physiopathology
Child, Preschool
Depression - etiology - physiopathology
Female
Growth Disorders - drug therapy - physiopathology - psychology
Hormone Replacement Therapy
Human Growth Hormone - administration & dosage - deficiency - therapeutic use
Humans
Interpersonal Relations
Male
Parents
Quality of Life
Questionnaires
Self Concept
Severity of Illness Index
Sweden
Time Factors
Abstract
To evaluate effects of growth hormone (GH) treatment on behaviour and psychosocial characteristics in short-stature children.
99 referred prepubertal non-familiar short-stature children (32 GH deficiency; 67 idiopathic short stature) aged 3-11 years, randomized to fixed or individual GH doses and their parents completed questionnaires (Child Behaviour Checklist, Birleson Depression Self-Report Scale, Abbreviated Parent-Teacher Questionnaire, I Think I Am, Well-Being Visual-Analogue Scales for Short-Stature Children) at baseline (BL) and after 3, 12, and 24 months.
At BL, children showed higher levels of internalizing behaviour (p
PubMed ID
21304250 View in PubMed
Less detail

Insight into human pubertal growth by applying the QEPS growth model.

https://arctichealth.org/en/permalink/ahliterature286276
Source
BMC Pediatr. 2017 Apr 19;17(1):107
Publication Type
Article
Date
Apr-19-2017
Author
Anton Holmgren
Aimon Niklasson
Lars Gelander
A Stefan Aronson
Andreas F M Nierop
Kerstin Albertsson-Wikland
Source
BMC Pediatr. 2017 Apr 19;17(1):107
Date
Apr-19-2017
Language
English
Publication Type
Article
Keywords
Adolescent
Body Height - physiology
Child
Female
Growth Charts
Humans
Longitudinal Studies
Male
Models, Biological
Puberty - physiology
Sweden
Abstract
Computerized mathematical models describing absolute and relative individual growth during puberty in both cm and standard deviation (SD)-scores are lacking. The present study aimed to fill this gap, by applying the QEPS-model that delineates mathematically the specific pubertal functions of the total growth curve.
Study population used was the individual growth curves of the longitudinally followed cohort GrowUp1974 Gothenburg (n = 2280). The QEPS-model describes total height as (T)otal-function: a combination of four shape-invariant growth functions, modified by time-scale and height-scale parameters: a (Q)uadratic-function for the continuous growth from fetal life to adulthood; a negative (E)xponential-function adds the rapid, declining fetal/infancy growth; a (P)ubertal-function the specific pubertal growth spurt; a (S)top-function the declining growth until adult height. A constructed variable, MathSelect, was developed for assessing data-quality. CIs and SD-scores for growth estimates were calculated for each individual. QEPS-model estimates used for pubertal growth; from the T-function: onset of puberty as minimal height velocity (AgeT ONSET ); mid-puberty as peak height velocity (AgeT PHV ); end of puberty as height velocity decreased to 1 cm/year (AgeT END ); duration of different intervals and gain (AgeT ONSET-END and Tpubgain); from the P-function: onset of puberty, estimated as growth at 1% or 5% (AgeP1 , AgeP5); mid-puberty as 50% (AgeP50) and PHV (AgeP PHV ); end of pubertal growth at 95 or 99% (AgeP95, AgeP99); duration of different intervals and pubertal gain (Ppubgain; P max ); from the QES-function: gain (QESpubgain) . RESULTS: Application of these mathematical estimates for onset, middle and end of puberty of P-function, QES-function, and T-function during puberty showed: the later the onset of puberty, the greater the adult height; pubertal gain due to the P-function growth was independent of age at onset of puberty; boys had higher total gain during puberty due to P-function growth than to QES-function growth; for girls it was reversed.
QEPS is the first growth model to provide individualized estimates of both the specific pubertal growth function and the total growth during puberty, with accompanying SD-scores and Cis for each individual. These QEPS-derived estimates enable more in-depth analysis of different aspects of pubertal growth than previously possible.
Notes
Cites: BMC Med Inform Decis Mak. 2007 Dec 12;7:4018076760
Cites: Acta Odontol Scand. 1980;38(1):57-676929640
Cites: Pediatr Res. 2000 Oct;48(4):475-8411004238
Cites: Ann Hum Biol. 1978 May;5(3):253-67686666
Cites: Triangle. 1966;7(6):240-35920758
Cites: Endocr Rev. 2003 Oct;24(5):668-9314570750
Cites: Ann Hum Biol. 1978 Sep;5(5):421-34727700
Cites: Horm Res. 2003;60(Suppl 1):27-3512955015
Cites: Int J Epidemiol. 2010 Dec;39(6):1558-6620647267
Cites: BMC Med Inform Decis Mak. 2009 Jan 12;9:119138407
Cites: Pediatrics. 2008 Apr;121(4):e885-9118381517
Cites: Ann Hum Biol. 1978 Jan;5(1):1-24646321
Cites: Arch Dis Child. 1969 Jun;44(235):291-3035785179
Cites: Ann Hum Biol. 1976 Mar;3(2):109-261275435
Cites: Horm Res Paediatr. 2014;82(3):158-7025170833
Cites: Acta Paediatr. 2000 Jun;89(6):637-4310914954
Cites: Acta Paediatr Scand Suppl. 1976;(258):7-761066960
Cites: Horm Res. 2005;63(2):95-10115735371
Cites: Annu Rev Anthropol. 1999;28:109-5312295621
Cites: Arch Dis Child. 1976 Mar;51(3):170-9952550
Cites: J Clin Endocrinol Metab. 1997 Feb;82(2):541-99024251
Cites: J Theor Biol. 2016 Oct 7;406:143-6527297288
Cites: Am J Epidemiol. 1999 Oct 1;150(7):747-5510512428
Cites: Arch Dis Child. 1970 Feb;45(239):13-235440182
Cites: BMC Endocr Disord. 2008 Sep 25;8:1018817534
Cites: Acta Paediatr. 2002;91(7):739-5412200898
Cites: Ann Hum Biol. 2013 May;40(3):298-923461542
Cites: Acta Paediatr Scand. 1987 May;76(3):478-883604665
Cites: Ann Hum Biol. 1991 Jan-Feb;18(1):47-562009005
Cites: Ann Hum Biol. 1998 Mar-Apr;25(2):101-159533510
Cites: Horm Res Paediatr. 2013;80(2):100-1023988590
Cites: Pediatr Endocrinol Rev. 2014 Mar;11(3):341-5324716402
Cites: J Clin Endocrinol Metab. 2011 Feb;96(2):525-3321147886
Cites: Acta Paediatr Scand Suppl. 1987;337:12-293481178
Cites: J Pediatr. 1985 Sep;107(3):317-293875704
Cites: PLoS One. 2008 Jul 16;3(7):e272818628945
Cites: Horm Res Paediatr. 2012;78(4):218-2523075676
Cites: Endocr Dev. 2005;8:1-1415722614
Cites: Acta Paediatr Scand Suppl. 1989;350:70-942801108
Cites: BMC Pediatr. 2008 Feb 29;8:818307822
PubMed ID
28424059 View in PubMed
Less detail

When do short children realize they are short? Prepubertal short children's perception of height during 24 months of catch-up growth hormone treatment.

https://arctichealth.org/en/permalink/ahliterature125092
Source
Horm Res Paediatr. 2012;77(4):241-9
Publication Type
Article
Date
2012
Author
John E Chaplin
Berit Kriström
Björn Jonsson
Maria Halldin Stenlid
A Stefan Aronson
Jovanna Dahlgren
Kerstin Albertsson-Wikland
Author Affiliation
Göteborg Pediatric Growth Research Centre, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. john.chaplin@vgregion.se
Source
Horm Res Paediatr. 2012;77(4):241-9
Date
2012
Language
English
Publication Type
Article
Keywords
Attitude to Health
Body Height - drug effects
Body Image
Child
Child Development
Child, Preschool
Female
Growth Disorders - drug therapy - psychology
Hormone Replacement Therapy
Human Growth Hormone - deficiency - therapeutic use
Humans
Male
Parent-Child Relations
Parents
Questionnaires
Recombinant Proteins - therapeutic use
Sex Characteristics
Sweden
Time Factors
Abstract
To examine perceived height during the first 24 months of growth hormone (GH) treatment in short prepubertal children.
Ninety-nine 3- to 11-year-old short prepubertal children with either isolated GH deficiency (n = 32) or idiopathic short stature (n = 67) participated in a 24-month randomized trial of individualized or fixed-dose GH treatment. Children's and parents' responses to three perceived height measures: relative height (Silhouette Apperception Test), sense of height (VAS short/tall), and judgment of appropriate height (yes/no) were compared to measured height.
Children and parents overestimated height at start (72%, 54%) and at 24 months (52%, 30%). Short children described themselves as tall until 8.2 years (girls) and 9 years (boys). Prior to treatment, 38% of children described their height as appropriate and at 3 months, 63%. Mother's height, parental sense of the child's tallness and age explained more variance in children's sense of tallness (34%) than measured height (0%).
Short children and parents overestimate height; a pivotal age exists for comparative height judgments. Even a small gain in height may be enough for the child to feel an appropriate age-related height has been reached and to no longer feel short.
PubMed ID
22516981 View in PubMed
Less detail

8 records – page 1 of 1.